Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states.
- DOI
- 10.21203/rs.3.rs-10539539/v1
- Published
- 2026 Aug 6
- Container
- Research square
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21203/rs.3.rs-10539539/v1,
title = {Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states.},
author = {Hu Y and Maspourour F and Wang Q and Huang A and Barsoumian H and Rafiq Z and Hoffman A and Robinson D and Wang J and Welsh JW},
year = {2026},
journal = {Research square},
doi = {10.21203/rs.3.rs-10539539/v1},
url = {https://doi.org/10.21203/rs.3.rs-10539539/v1}
}RIS
TY - JOUR TI - Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states. AU - Hu Y AU - Maspourour F AU - Wang Q AU - Huang A AU - Barsoumian H AU - Rafiq Z AU - Hoffman A AU - Robinson D AU - Wang J AU - Welsh JW PY - 2026 JO - Research square DO - 10.21203/rs.3.rs-10539539/v1 UR - https://doi.org/10.21203/rs.3.rs-10539539/v1 ER -
APA
Y, H., F, M., Q, W., A, H., H, B., Z, R., A, H., D, R., J, W., & JW, W. (2026). Tumor Treating Fields (TTFields) sensitize anti-PD1-resistant lung tumors to PD1 blockade and remodel myeloid and lymphoid states.. Research square. https://doi.org/10.21203/rs.3.rs-10539539/v1
Source records
- pubmed · retrieved 2026-09-26T01:36:41.464Z